retatrutide nonalcoholic fatty liver disease nash trial Pipeline Xia & He Publishing

"There's up to 50% of individuals who go on to GLP-1 for weight management who stop taking the drug within 12 to 14 months for a variety of reasons, side effects gastrointestinal, behavioral, or otherwise

While the kinetic rate constants could not be accurately determined for GLP-1 QMP, GLP-1 QMP/LX (0.2 nM) showed an almost 600-fold higher binding affinity compared to GLP-1 WT (Fig

During your pre-operative consultation, explicitly mention every medication you take, including compounded GLP-1 injections from sources like PlexusDx

They investigate how a compound is absorbed, distributed, metabolized, and eliminated (ADME) from the body

doi: 10.1210/jcem.87.3.8355 132 de HeerJRasmussenCCoyDHHolstJJ